BioAdaptives, Inc. investigates, markets, and distributes natural plant, fungi, and algal-based products and medical devices for humans and animals. The company offers MyndMed for immediate cognitive enhancement, medium-term resilience and memory gains, and long-term neuroprotection and cognitive health; Zeranovia, a weight loss enhancer; Wynovia to help reduce the loss of lean muscle mass during dieting; and Xcellara, a regenerative wellness solution. It also provides canine products under the PawPa brand; dog chew products under the Regen brand; and Lung Flute, a medical device. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.
Frequently asked questions
What sector does BioAdaptives Inc (BDPT) operate in?
BioAdaptives Inc belongs to the Consumer Staples sector and operates in the Packaged Foods industry.
What is BioAdaptives Inc (BDPT) current stock price?
As of the latest data, BioAdaptives Inc stock price is $0.00, with a previous close of $0.00. BioAdaptives Inc lost -$0.00 in the last trading session, representing a -6.67% loss.
What is BioAdaptives Inc (BDPT) current market capitalization?
BioAdaptives Inc market cap is approximately 275.70 thousand.
What is BioAdaptives Inc (BDPT) Earnings Per Share (EPS)?
The trailing EPS is -$0.11.
What is BioAdaptives Inc (BDPT) EBITDA?
BioAdaptives Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -195.68 thousand.
Does BioAdaptives Inc (BDPT) pay dividends?
No. BioAdaptives Inc does not pay a dividend.
What is BioAdaptives Inc (BDPT) beta (volatility) score?
BioAdaptives Inc has a beta of 1.092, meaning its volatility is roughly in line with the market.
